文献速递神经核医学肿瘤 PET/CT

甲氧氯普胺止吐治疗致口舌咀嚼综合征在18F-FDG PET/CT上表现为「热舌」

"Hot Tongue and Mouth" on 18F-FDG PET/CT Due to Buccolingual Masticatory Syndrome, Caused by Metoclopramide Antiemetic Treatment.
PubMed 文献 · Clin Nucl Med · 2024-11-20

本文报告一例66岁男性,因甲氧氯普胺止吐治疗导致口舌咀嚼综合征(迟发性运动障碍),18F-FDG PET/CT显示舌、唇、颊及咀嚼肌强烈FDG摄取,并伴有对应口舌区域的感觉运动皮层激活。既往「热舌」见于抗精神病药所致迟发性运动障碍,本例以面下部运动皮层显著激活为特点。

要点

  • 口舌咀嚼综合征表现为舌、唇、颊及咀嚼肌不自主重复运动。
  • 18F-FDG PET/CT可见舌、唇、颊及咀嚼肌强烈FDG摄取。
  • 本例口舌咀嚼综合征由甲氧氯普胺止吐治疗引起。

核心结论

  • 口舌咀嚼综合征可由甲氧氯普胺止吐治疗引起,18F-FDG PET/CT表现为舌、唇、颊及咀嚼肌强烈FDG摄取,并伴有对应口舌区域的感觉运动皮层激活。

研究设计与样本

  • 病例报告,报告一例66岁男性患者。

主要发现

  • 18F-FDG PET/CT显示舌、唇、颊及咀嚼肌强烈FDG摄取,并可见对应口舌区域的感觉运动皮层与运动皮层明显激活。
  • 患者患口舌咀嚼综合征,特征为迟发性运动障碍,即舌、唇、颊及咀嚼肌不自主重复运动。
  • 本例口舌咀嚼综合征由甲氧氯普胺止吐治疗引起。
  • 既往「热舌」曾在因抗精神病药治疗导致迟发性运动障碍的患者中于18F-FDG PET/CT上描述,但本例面下部运动皮层的明显激活使其与众不同。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We present a case of a 66-year-old man, where 18F-FDG PET/CT revealed intense FDG uptake in the tongue, lips, cheeks, and chewing musculature and distinct activation of the somatosensory and motor cortex corresponding to the mouth and tongue. The patient suffered from buccolingual masticatory syndrome, characterized by tardive dyskinesia, meaning uncontrollable, repetitive movements of the tongue, lips, cheeks, and masticatory musculature. In this case, the buccolingual masticatory syndrome was caused by metoclopramide antiemetic treatment. "Hot tongue" was previously described on 18F-FDG PET/CT in patients with tardive dyskinesia due to antipsychotic treatment, but the distinct activation of the lower facial motor cortex makes the present case stand out.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Jochumsen MR, Kramer SMJ. "Hot Tongue and Mouth" on 18F-FDG PET/CT Due to Buccolingual Masticatory Syndrome, Caused by Metoclopramide Antiemetic Treatment. Clin Nucl Med. 2024. PMID: 39774165. doi:10.1097/RLU.0000000000005564

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。